Posted June 01, 2018 05:04:06In the wake of the RCAF’s recent announcement that its RCP 2,000 price for its air purifiers would be cut to just RCP 1,800, many consumers are understandably concerned about the health risks associated with these air filters.
A new report from Consumer Reports reveals some of the more interesting statistics that come out of this research.
Consumer Reports tested two types of filters: the RAC Pro (designed to prevent lung cancer) and the RSC Pro (which is designed to combat respiratory infections).
They found that both filters contained about the same amount of active ingredients as a standard filter, and that these filters were effective at preventing certain lung cancers.
However, the RPCs filters did significantly better than the RRCs at preventing respiratory infections, which could cause pneumonia.
The RPC filter had about 3,000 times more active ingredients than a standard oneThe RRC filter had 4,000-5,000 more active ingredientThe RSC filter had 10,000+ more active Ingredients The RCP filters did better than a normal filter by about 1,000 pointsThe RAC filters did not have more active materials than a typical standard filterThe RNCs filters had 1,500 times more than the standard filterAnd while this was a pretty small difference, it’s significant.
If you take into account the amount of chemicals and toxic compounds in these filters, it is clear that the RCCs filter is going to be a much more effective and effective filter than a regular filter.
The RRC filters also had more active components, and were less expensive.
The report also showed that consumers were also significantly more likely to report negative health effects than they were to report positive health effects.
In fact, in two out of three cases, consumers reported negative health outcomes from the ROC filters.
Consumer advocates are concerned that this information could be used by pharmaceutical companies to increase their profits by charging higher prices for their filters, which are widely used in the U.S. These high prices could make ROCs filters more expensive to use than standard filters.
In addition, the FDA has made its ROC air filters subject to a “preliminary review” by the agency, which means that they have not yet been approved for use in the United States.
These air filters will need to undergo further testing before they can be marketed to the public.
In a statement to Business Insider, ROC said that it is still evaluating all the available information and that it would provide updates as it becomes available.